CIK: 1262325 - Address: C/O Bridgebio Pharma, Inc., 3160 Porter Dr., Suite 250, Palo Alto, CA 94304
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/18/20 21:30
12/16/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesAguiar EricCADS.d-51051.000-10-1000D
11/18/20 20:06
11/16/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesAguiar EricCADS.d-1,39646.520-30-1000D
7/16/20 18:50
7/15/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesAguiar EricCADS.d-34033.990-10-1000D
1/24/20 18:43
1/22/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsAguiar EricNYDS.d-11456.480-2-621I
1/10/20 19:46
1/9/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsAguiar EricNYDS.d-1,69256.390-30-961M
12/18/19 21:39
12/16/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsAguiar EricNYDS.d-19555.130-4-1000I
12/11/19 21:43
12/9/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsAguiar EricNYDS.d-22455.110-4-1000I
11/22/19 21:37
11/20/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsAguiar EricNYDS.dm-42052.670-8-1000I
9/13/19 16:34
9/11/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsAguiar EricNYDS.d-45045.000-10-1000I
11/28/18 19:17
11/27/18
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesAguiar EricCADS-13513.500-10-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact